Concepedia
Statistics
Publications
15
Citations
2.4K
H-Index
Active since
2010
Affiliations
Massachusetts General Hospital(Current)
Memorial Sloan Kettering Cancer Center
Guardant (United States)
Harvard University
Universidade de São Paulo
Emily Chin is an author at Massachusetts General Hospital specializing in medicine, oncology, and lung cancer.
Publications per year
2010–2021
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in <i>ALK</i> -Rearranged Lung Cancer
Justin F. Gainor, Leila Dardaei, Satoshi Yoda et al. · Cancer Discovery · 2016 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +10
Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer
Justin F. Gainor, Leila Dardaei, Satoshi Yoda et al. · European Journal of Cancer · 2016 · 195 citations
Medicine, Cancer Biology, Oncology +16
MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer
Ibiayi Dagogo‐Jack, Satoshi Yoda, Jochen K. Lennerz et al. · Clinical Cancer Research · 2020 · 194 citations · Full text
Medicine, Oncology, Pharmacology +17
Treatment with Next-Generation ALK Inhibitors Fuels Plasma <i>ALK</i> Mutation Diversity
Ibiayi Dagogo‐Jack, Marguerite Rooney, Rebecca J. Nagy et al. · Clinical Cancer Research · 2019 · 150 citations · Full text
Increased Hepatotoxicity Associated with Sequential Immune Checkpoint Inhibitor and Crizotinib Therapy in Patients with Non–Small Cell Lung Cancer
Emily Chin, Beow Y. Yeap, Lorin A. Ferris et al. · Journal of Thoracic Oncology · 2018 · 145 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 15